PlainRecalls
FDA Drug Moderate Class II Ongoing

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04

Reported: March 26, 2025 Initiated: March 7, 2025 #D-0278-2025

Product Description

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04

Reason for Recall

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Details

Recalling Firm
Slate Run Pharmaceuticals
Units Affected
56,790 bottles
Distribution
Product was distributed to 8 distributors who may have further distribute the product nationwide.
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04. Recalled by Slate Run Pharmaceuticals. Units affected: 56,790 bottles.
Why was this product recalled?
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 26, 2025. Severity: Moderate. Recall number: D-0278-2025.